Cedar Mountain Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-400
Closed -$40.6K 1169
2025
Q4
$40.6K Hold
400
0.01% 127
2025
Q3
$21.9K Hold
400
﹤0.01% 180
2025
Q2
$21.3K Hold
400
﹤0.01% 158
2025
Q1
$17.3K Hold
400
﹤0.01% 165
2024
Q4
$22.5K Hold
400
﹤0.01% 148
2024
Q3
$27.2K Hold
400
0.01% 125
2024
Q2
$16.9K Hold
400
﹤0.01% 149
2024
Q1
$27.6K Hold
400
0.01% 108
2023
Q4
$29.6K Hold
400
0.01% 102
2023
Q3
$27.3K Hold
400
0.01% 94
2023
Q2
$37.6K Hold
400
0.01% 84
2023
Q1
$27.1K Hold
400
0.01% 101
2022
Q4
$19.8K Hold
400
0.01% 106
2022
Q3
$13K Hold
400
﹤0.01% 132
2022
Q2
$16K Hold
400
0.01% 126
2022
Q1
$28K Hold
400
0.01% 104
2021
Q4
$31K Hold
400
0.01% 98
2021
Q3
$38K Hold
400
0.01% 84
2021
Q2
$50K Hold
400
0.02% 71
2021
Q1
$53K Hold
400
0.02% 70
2020
Q4
$53K Buy
+400
New +$48.4K 0.02% 67

Other funds holding EXAS

Cedar Mountain Advisors's EXAS Position: Q1 2026 in Review

Cedar Mountain Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 400 shares — an estimated $40.6K sold.

Cedar Mountain Advisors first reported a position in EXAS in Q4 2020 and held it in 21 quarters. The position peaked at $53K in Q1 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Cedar Mountain Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Cedar Mountain Advisors sold 400 Exact Sciences shares in Q1 2026, an estimated $40.6K.
  • Cedar Mountain Advisors first reported a position in Exact Sciences in Q4 2020 and held it in 21 quarters.
  • Cedar Mountain Advisors's Exact Sciences position peaked at $53K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Cedar Mountain Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.